PTN News and Press, Palatin Technologies Inc. From 03/28/25

2025-03-28 09:19:02 ET More on Palatin Technologies Palatin Technologies, Inc. (PTN) Q2 2025 Earnings Call Transcript Palatin's gets Orphan Drug status for its treatment for obesity from genetic disorder Palatin Technologies prices 4.69M shares in direct offering ...

Palatin Announces Positive Topline Results from Phase 2 Ulcerative Colitis (UC) Study of Oral Melanocortin-1 Receptor Agonist PL8177 PR Newswire Clinical Remission: Achieved in 33% of PL8177-treated patients versus 0% on placebo after eight weeks of treatment. Clinic...

2025-03-25 09:26:38 ET More on Palatin Technologies Palatin Technologies, Inc. (PTN) Q2 2025 Earnings Call Transcript Palatin Technologies prices 4.69M shares in direct offering Seeking Alpha’s Quant Rating on Palatin Technologies Historical earnings d...

Palatin's Oral MC4R Agonist PL7737 Receives FDA Orphan Drug Designation for Obesity Due to Leptin Receptor Deficiency PR Newswire Initiated IND-enabling toxicology program IND submission planned for 4Q25; Clinical data expected in 1H26 CRANBURY, N.J....

2025-02-15 05:41:35 ET Palatin Technologies, Inc. (PTN) Q2 2025 Earnings Conference Call February 13, 2024 11:00 AM ET Company Participants Carl Spana - CEO and President Stephen Wills - CFO, COO, Treasurer and Secretary Conference Call Participants Joe P...

2025-02-13 07:47:42 ET More on Palatin Technologies Palatin Technologies prices 4.69M shares in direct offering Palatin Technologies announces warrant exercise for ~$3.4M gross proceeds Seeking Alpha’s Quant Rating on Palatin Technologies Historical ea...

Palatin Reports Second Quarter Fiscal Year 2025 Financial Results and Provides Business Update PR Newswire Phase 2 obesity co-administration study with MC4R agonist bremelanotide plus GLP-1/GIP dual agonist tirzepatide Database lock completed Topline data rea...

2025-02-12 15:07:19 ET More on Palatin Technologies Palatin Technologies prices 4.69M shares in direct offering Palatin Technologies announces warrant exercise for ~$3.4M gross proceeds Seeking Alpha’s Quant Rating on Palatin Technologies Historical ea...

Palatin to Report Second Quarter Fiscal Year 2025 Results; Teleconference and Webcast to be held on February 13, 2025 PR Newswire CRANBURY, N.J. , Feb. 10, 2025 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE American: PTN) will announce its second quarter fisca...

2025-02-07 08:11:24 ET Read the full article on Seeking Alpha For further details see: Palatin Technologies prices 4.69M shares in direct offering